naproxen has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 3 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) | Trials (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) | Recent Studies (post-2010) (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 1,541 | 16 | 580 |
| Protein | Taxonomy | naproxen (IC50) | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.13 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| David, KC; Delgado, P; Graff, G; Haggard, KS; Hellberg, MR; Kessler, TL; Namil, A; Nixon, JC | 1 |
| Kourounakis, AP; Matralis, AN | 1 |
| Dahlborg, R; Day, CA; Jacob, RF; Mason, RP; Walter, MF; Weng, Y | 1 |
3 other study(ies) available for naproxen and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Novel esters and amides of nonsteroidal antiinflammatory carboxylic acids as antioxidants and antiproliferative agents.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carboxylic Acids; Cattle; Cell Division; Cells, Cultured; Child, Preschool; DNA; Endothelium, Vascular; Esters; Female; Humans; Lipid Peroxidation; Magnetic Resonance Spectroscopy; Molecular Structure | 1999 |
Optimizing the Pharmacological Profile of New Bifunctional Antihyperlipidemic/Antioxidant Morpholine Derivatives.
Topics: | 2019 |
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs.
Topics: Animals; Antioxidants; Celecoxib; Cholesterol, LDL; Chromans; Cyclooxygenase Inhibitors; Diclofenac; Humans; Ibuprofen; Isoprostanes; Isoxazoles; Lactones; Meloxicam; Naproxen; Oxidation-Reduction; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles | 2004 |